Jim Cramer’s 10 Go-To Stocks for Success
In a recent episode of Mad Money, Jim Cramer offers a perspective on Nvidia and its recent market behavior on Wednesday's episode of Mad Money, presenting a straightforward analysis of the company's stock...
Vertex Pharmaceuticals Inc / Ma (VRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,566,388 | $734,197,383 | -1% | 1.24% |
| 2. | AQR Capital Management Cliff Asness | 536,114 | $251,287,391 | -20% | 0.38% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 335,161 | $157,096,664 | -5% | 0.29% |
| 4. | 330,000 | $154,677,600 | +230% | 11.93% | |
| 5. | GLG Partners Noam Gottesman | 197,296 | $92,476,581 | -63% | 0.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $196.34 | 4,243 | Officer, Director | 73,754 | 2021-08-19 | Filing | |
| $195.14 | 5,757 | Officer, Director | 69,511 | 2021-08-19 | Filing | |
| $197.91 | 15,000 | Director | 41,210 | 2021-08-02 | Filing | |
| $218.79 | 3,905 | Director | 26,210 | 2020-11-10 | Filing | |
| $217.49 | 4,270 | Director | 22,305 | 2020-11-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $499.00 | 3,784 | Officer, Director | 9,994 | 2024-08-30 | Filing | |
| $500.00 | 646 | Director | 4,435 | 2024-08-30 | Filing | |
| $466.29 | 1,292 | Director | 4,435 | 2024-08-08 | Filing | |
| $476.75 | 2,280 | Officer | 23,259 | 2024-08-07 | Filing | |
| $508.00 | 5,295 | Director | 40,000 | 2024-08-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,282,180 | $9,066,396,221 | 0.19% | |
| 2. | 21,881,203 | $8,903,242,772 | 0.22% | |
| 3. | 21,805,770 | $8,872,586,480 | 1.57% | |
| 4. | 12,979,511 | $5,281,233,200 | 0.4% | |
| 5. | 12,083,818 | $4,916,784,706 | 0.23% |
News See All
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2024 Earnings Call Transcript August 1, 2024Vertex Pharmaceuticals Incorporated misses on earnings expectations.
10 Best Healthcare Stocks to Buy According to Hedge Funds
Healthcare stocks are often considered a defensive investment during times of economic uncertainty.
Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?
We recently published a list Analyst Recommends 10 Best Stocks to Diversify Your Portfolio Away from Mega-Cap Tech and AI Stocks. Since Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks 7th on ...
11 Best Feminist Stocks To Invest In
With the passage of time, the role of women in the modern day workplace has slowly started to grow.
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the Leading Gene Therapy Stock to Buy Now?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is the leading gene therapy stock to ...
9 Best Gene Therapy Stocks to Buy Now
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and understand the reasons behind...
Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07.
Billionaire Hedge Funds
